Table 2. Cancer patients detected using TEC-Seq.

NA, not applicable.

Cancer type	Patients (n)	Patients with ctDNA alterations (n)	Fraction of patients with ctDNA alterations (%)
Colorectal
I	8	4	50
II	9	8	89
III	10	9	90
IV	15	14	93
I–IV	42	35	83
Lung
I	29	13	45
II	32	23	72
III	4	3	75
IV	6	5	83
I–IV	71	44	62
Ovarian
I	24	16	67
II	4	3	75
III	8	6	75
IV	6	5	83
I–IV	42	30	71
Breast
I	3	2	67
II	29	17	59
III	13	6	46
IV	0	NA	NA
I–IV	45	25	56
All
I and II	138	86	62
III and IV	62	48	77
I–IV	200	134	67